Skip to main content

This transaction represents a great milestone for Pharming. The license of CDZ173 is our first step towards building off the commercial success of Ruconest in HAE to grow and diversify our portfolio.

- Sijmen de Vries - CEO
Cookies: This website uses cookies Check the cookies page for more information Accept Decline